vs

Side-by-side financial comparison of BGSF, INC. (BGSF) and Neuronetics, Inc. (STIM). Click either name above to swap in a different company.

Neuronetics, Inc. is the larger business by last-quarter revenue ($41.8M vs $22.0M, roughly 1.9× BGSF, INC.). BGSF, INC. runs the higher net margin — -5.3% vs -17.2%, a 12.0% gap on every dollar of revenue. On growth, Neuronetics, Inc. posted the faster year-over-year revenue change (85.7% vs -9.4%). BGSF, INC. produced more free cash flow last quarter ($1.7M vs $692.0K). Over the past eight quarters, Neuronetics, Inc.'s revenue compounded faster (54.9% CAGR vs -5.3%).

BGSF Inc. is a leading U.S.-headquartered workforce solutions firm that provides tailored staffing, talent recruitment, and end-to-end workforce management services. It serves core segments including information technology, healthcare, professional administration, light industrial, and creative industries, catering to small, mid-sized and large enterprise clients across North America.

Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology. 

BGSF vs STIM — Head-to-Head

Bigger by revenue
STIM
STIM
1.9× larger
STIM
$41.8M
$22.0M
BGSF
Growing faster (revenue YoY)
STIM
STIM
+95.1% gap
STIM
85.7%
-9.4%
BGSF
Higher net margin
BGSF
BGSF
12.0% more per $
BGSF
-5.3%
-17.2%
STIM
More free cash flow
BGSF
BGSF
$978.0K more FCF
BGSF
$1.7M
$692.0K
STIM
Faster 2-yr revenue CAGR
STIM
STIM
Annualised
STIM
54.9%
-5.3%
BGSF

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BGSF
BGSF
STIM
STIM
Revenue
$22.0M
$41.8M
Net Profit
$-1.2M
$-7.2M
Gross Margin
35.0%
52.0%
Operating Margin
-17.6%
-12.1%
Net Margin
-5.3%
-17.2%
Revenue YoY
-9.4%
85.7%
Net Profit YoY
-18.2%
43.2%
EPS (diluted)
$-0.12
$-0.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BGSF
BGSF
STIM
STIM
Q4 25
$22.0M
$41.8M
Q3 25
$26.9M
$37.3M
Q2 25
$23.5M
$38.1M
Q1 25
$20.9M
$32.0M
Q4 24
$24.3M
$22.5M
Q3 24
$29.8M
$18.5M
Q2 24
$25.7M
$16.4M
Q1 24
$24.5M
$17.4M
Net Profit
BGSF
BGSF
STIM
STIM
Q4 25
$-1.2M
$-7.2M
Q3 25
$-5.8M
$-9.0M
Q2 25
$-3.7M
$-10.1M
Q1 25
$-722.0K
$-12.7M
Q4 24
$-981.0K
$-12.7M
Q3 24
$-804.0K
$-13.3M
Q2 24
$-761.0K
$-9.8M
Q1 24
$-792.0K
$-7.9M
Gross Margin
BGSF
BGSF
STIM
STIM
Q4 25
35.0%
52.0%
Q3 25
35.9%
45.9%
Q2 25
35.8%
46.6%
Q1 25
36.2%
49.2%
Q4 24
35.9%
66.2%
Q3 24
35.9%
75.6%
Q2 24
37.3%
74.0%
Q1 24
38.1%
75.1%
Operating Margin
BGSF
BGSF
STIM
STIM
Q4 25
-17.6%
-12.1%
Q3 25
-3.5%
-19.6%
Q2 25
-18.8%
-21.1%
Q1 25
1.6%
-34.4%
Q4 24
-15.7%
-51.0%
Q3 24
-3.4%
-41.7%
Q2 24
-5.7%
-51.7%
Q1 24
1.7%
-39.4%
Net Margin
BGSF
BGSF
STIM
STIM
Q4 25
-5.3%
-17.2%
Q3 25
-21.6%
-24.3%
Q2 25
-15.9%
-26.6%
Q1 25
-3.5%
-39.6%
Q4 24
-4.0%
-56.4%
Q3 24
-2.7%
-72.0%
Q2 24
-3.0%
-59.8%
Q1 24
-3.2%
-45.2%
EPS (diluted)
BGSF
BGSF
STIM
STIM
Q4 25
$-0.12
$-0.10
Q3 25
$-0.52
$-0.13
Q2 25
$-0.34
$-0.15
Q1 25
$-0.06
$-0.21
Q4 24
$-0.34
Q3 24
$-0.07
$-0.44
Q2 24
$-0.07
$-0.33
Q1 24
$-0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BGSF
BGSF
STIM
STIM
Cash + ST InvestmentsLiquidity on hand
$28.1M
Total DebtLower is stronger
$65.8M
Stockholders' EquityBook value
$48.1M
$22.4M
Total Assets
$57.8M
$141.6M
Debt / EquityLower = less leverage
2.94×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BGSF
BGSF
STIM
STIM
Q4 25
$28.1M
Q3 25
$41.2M
$28.0M
Q2 25
$2.8M
$11.0M
Q1 25
$2.0M
$20.2M
Q4 24
$32.0K
$18.5M
Q3 24
$262
$20.9M
Q2 24
$226
$42.6M
Q1 24
$50
$47.7M
Total Debt
BGSF
BGSF
STIM
STIM
Q4 25
$65.8M
Q3 25
$65.7M
Q2 25
$55.5M
Q1 25
$55.3M
Q4 24
$55.2M
Q3 24
$46.0M
Q2 24
$59.8M
Q1 24
$59.4M
Stockholders' Equity
BGSF
BGSF
STIM
STIM
Q4 25
$48.1M
$22.4M
Q3 25
$50.7M
$27.4M
Q2 25
$78.3M
$27.1M
Q1 25
$81.8M
$35.5M
Q4 24
$82.3M
$27.7M
Q3 24
$82.9M
$9.4M
Q2 24
$83.2M
$19.4M
Q1 24
$83.6M
$27.7M
Total Assets
BGSF
BGSF
STIM
STIM
Q4 25
$57.8M
$141.6M
Q3 25
$83.6M
$145.5M
Q2 25
$149.7M
$134.7M
Q1 25
$152.3M
$142.0M
Q4 24
$150.1M
$140.9M
Q3 24
$157.3K
Q2 24
$159.8K
$96.8M
Q1 24
$170.6K
$103.8M
Debt / Equity
BGSF
BGSF
STIM
STIM
Q4 25
2.94×
Q3 25
2.40×
Q2 25
2.05×
Q1 25
1.56×
Q4 24
1.99×
Q3 24
4.90×
Q2 24
3.08×
Q1 24
2.15×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BGSF
BGSF
STIM
STIM
Operating Cash FlowLast quarter
$1.7M
$908.0K
Free Cash FlowOCF − Capex
$1.7M
$692.0K
FCF MarginFCF / Revenue
7.6%
1.7%
Capex IntensityCapex / Revenue
0.1%
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-16.0K
$-21.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BGSF
BGSF
STIM
STIM
Q4 25
$1.7M
$908.0K
Q3 25
$-4.8M
$-785.0K
Q2 25
$2.2M
$-3.5M
Q1 25
$1.1M
$-17.0M
Q4 24
$3.2M
$-8.6M
Q3 24
$6.5M
$-5.4M
Q2 24
$7.3M
$-5.0M
Q1 24
$7.4M
$-12.0M
Free Cash Flow
BGSF
BGSF
STIM
STIM
Q4 25
$1.7M
$692.0K
Q3 25
$-4.9M
$-899.0K
Q2 25
$2.1M
$-3.8M
Q1 25
$1.0M
$-17.2M
Q4 24
$2.5M
$-8.7M
Q3 24
$6.5M
$-5.8M
Q2 24
$7.3M
$-5.6M
Q1 24
$6.9M
$-12.4M
FCF Margin
BGSF
BGSF
STIM
STIM
Q4 25
7.6%
1.7%
Q3 25
-18.1%
-2.4%
Q2 25
9.1%
-9.9%
Q1 25
5.0%
-53.8%
Q4 24
10.2%
-38.6%
Q3 24
21.7%
-31.3%
Q2 24
28.5%
-34.0%
Q1 24
28.1%
-71.1%
Capex Intensity
BGSF
BGSF
STIM
STIM
Q4 25
0.1%
0.5%
Q3 25
0.4%
0.3%
Q2 25
0.0%
0.7%
Q1 25
0.1%
0.7%
Q4 24
3.0%
0.4%
Q3 24
0.0%
2.1%
Q2 24
0.0%
3.7%
Q1 24
2.0%
2.2%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BGSF
BGSF

Contract Field Talent$21.4M97%
Other$595.0K3%

STIM
STIM

Segment breakdown not available.

Related Comparisons